Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

0.00%

8.0¢ kazia therapeutics limited

Sell, Sell, Sell., page-35

First 35 Last

Share
Profile

Follow
Gofish1

910 Posts.

101

19/07/16

15:59

Post #: 18308632
Share

Originally posted by rusty02 ↑

The last update was on the 2nd May pertaining to events in April, hence 3 months of no updates.
Sent this email on the 14th but unfortunately no response;

Hi Kym,
Just touching base as virtually no ANN have been made and little updates on progress.
From my understanding the IND application is in September for both the US and AUST.
Was there a reason for the delay in application from earlier this year.?
Is the manufacturing process and the clinical trial for Cantrixil still on target for later this year?
Anisina toxicology. Will this be ANN and update on progress moving into clinical trial?
Once clinical trials commence will there be more ASX communication’s to Sher’s?
Its also my understanding that many investors have asked for ASX updates. Is there any reason not to provide any; eg, corporate governance, T/O etc?
Hopefully news soon, sentiment is quite low.
Cheers and thanks in advance.

"WTF is going on with this company........." I hear............totally agree.......and we now have a MC of under CR........Irresponsible to let things slip this far, don't you think management regardless of what the lab team are up to. My sentiment of hold is on thin ice with this mob. (management that is)

Expand

Is that when the June Newsletter came out?
http://www.novogen.com/pdf/Novogen_Investor_Newsletter_June_2016.pdf

NRT Price at posting: 10.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What each US election outcome would mean for Australian companies & investors

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers